Following a primary infection, Herpes simplex virus type 1 (HSV-1) invades sensory neurons of the trigeminal ganglion (TG), where it establishes a life-long latent (quiescent) infection. During latency no virus is produced and viral gene expression is largely repressed. In some humans periodic reactivation from the latent state results in HSV-1 release at the nerve termini, leading to potentially blinding herpes keratitis tha is characterized by inflammation, scarring, and progressive loss of vision. Devising methods to keep the virus in a latent state will provide crucial intervention in this blinding process. Work supported by this grant has contributed to a paradigm shift in understanding of HSV-1 latency from what was once considered a silent infection that is ignored by the host immune system to what is now believed to be a more dynamic infection in which viral gene expression in some neurons triggers CD8+ T lymphocytes to inhibit reactivation. While a role for CD8+ T cells in controlling HSV-1 latency is gaining wider acceptance, the involvement of CD4+ T cells that are also retained in latently infected TG has been largely ignored. The goals of the current application are to:
Aim 1) Define the role of CD4+ and TCR- ?/?+ T cells in directly or indirectly inhibiting HSV-1 reactivation. Explore novel approaches to enhance the number of functional TG-resident T cells by:
Aim 2 altering the microenvironment of the latently infected TG to make it more accessible to circulating HSV-specific T cells;
and Aim 3) increasing the proliferation and function of TG-resident T cells by blocking the inhibitory receptors they express and eliminating inhibitory cytokines in the TG. While antiviral drugs appear to be useful for reducing the rate of recurrence of herpetic disease, we believe arming the immune system for the task is a superior approach in that it does not require life-long compliance with a drug treatment regimen, eliminates possible side-effects of long term drug use, and does not create the potential for drug resistant viral mutants. Therefore, we believe the treatment strategies developed in this proposal could greatly reduce the rate of recurrence herpetic eye disease and its blinding consequences.

Public Health Relevance

Herpes simplex virus type 1 (HSV-1) keratitis is the leading infectious cause of blindness in the United States. Reactivation of HSV-1 from a latent (quiescent) state leads to recurrent bouts of corneal infection, inflammation, scarring, and progressive vision loss. Studies in this proposal are designed to manipulate a patient's immune system to prevent HSV-1 reactivation from latency and the potentially blinding inflammatory sequelae.

National Institute of Health (NIH)
National Eye Institute (NEI)
Research Project (R01)
Project #
Application #
Study Section
Program Officer
Mckie, George Ann
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
Schools of Medicine
United States
Zip Code
Jeon, Sohyun; Rowe, Alexander M; Carroll, Kate L et al. (2018) PD-L1/B7-H1 Inhibits Viral Clearance by Macrophages in HSV-1-Infected Corneas. J Immunol 200:3711-3719
Rowe, Alexander M; Yun, Hongmin; Hendricks, Robert L (2017) Exposure Stress Induces Reversible Corneal Graft Opacity in Recipients With Herpes Simplex Virus-1 Infections. Invest Ophthalmol Vis Sci 58:35-41
Rowe, Alexander M; Yun, Hongming; Treat, Benjamin R et al. (2017) Subclinical Herpes Simplex Virus Type 1 Infections Provide Site-Specific Resistance to an Unrelated Pathogen. J Immunol 198:1706-1717
Yun, Hongmin; Lathrop, Kira L; Hendricks, Robert L (2016) A Central Role for Sympathetic Nerves in Herpes Stromal Keratitis in Mice. Invest Ophthalmol Vis Sci 57:1749-56
Kuffova, Lucia; Knickelbein, Jared E; Yu, Tian et al. (2016) High-Risk Corneal Graft Rejection in the Setting of Previous Corneal Herpes Simplex Virus (HSV)-1 Infection. Invest Ophthalmol Vis Sci 57:1578-87
Buela, Kristine-Ann G; Hendricks, Robert L (2015) Cornea-infiltrating and lymph node dendritic cells contribute to CD4+ T cell expansion after herpes simplex virus-1 ocular infection. J Immunol 194:379-87
St Leger, Anthony J; Jeon, Sohyun; Hendricks, Robert L (2013) Broadening the repertoire of functional herpes simplex virus type 1-specific CD8+ T cells reduces viral reactivation from latency in sensory ganglia. J Immunol 191:2258-65
Rowe, A M; St Leger, A J; Jeon, S et al. (2013) Herpes keratitis. Prog Retin Eye Res 32:88-101
Jeon, Sohyun; St Leger, Anthony J; Cherpes, Thomas L et al. (2013) PD-L1/B7-H1 regulates the survival but not the function of CD8+ T cells in herpes simplex virus type 1 latently infected trigeminal ganglia. J Immunol 190:6277-86
Kinchington, Paul R; Leger, Anthony J St; Guedon, Jean-Marc G et al. (2012) Herpes simplex virus and varicella zoster virus, the house guests who never leave. Herpesviridae 3:5

Showing the most recent 10 out of 33 publications